Evidence map›Paper›PMID 31479195›Full record

ArticleJournal of clinical hypertension (Greenwich, Conn.)2019

Blood pressure control and cardiovascular risk profile in hypertensive patients under specialist care in Argentina: Results from the CHARTER study.

Marcos Marín, Jessica Barochiner, Pablo Rodríguez, Nicolás Renna, Carlos Castellaro, Walter Espeche, Alejandro De Cerchio, Mildren Del Sueldo, Sergio Vissani, Judith Zilberman

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Journal of clinical hypertension (Greenwich, Conn.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. May Measurement Month 2022: an analysis of blood pressure screening results from Argentina.European heart journal supplements : journal of the European Society of Cardiology · 2025
    Article
  4. May Measurement Month 2019: an analysis of blood pressure screening results from Argentina.European heart journal supplements : journal of the European Society of Cardiology · 2021
    Article
  5. Adherence to antihypertensive drug treatment in Argentina: A multicenter study.Journal of clinical hypertension (Greenwich, Conn.) · 2020
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 1 country.

Marcos MarínArgentinian Society of Hypertension, Buenos Aires, Argentina.
Jessica BarochinerArgentinian Society of Hypertension, Buenos Aires, Argentina.ORCID 0000-0002-2176-9762
Pablo RodríguezArgentinian Society of Hypertension, Buenos Aires, Argentina.
Nicolás RennaArgentinian Society of Hypertension, Buenos Aires, Argentina.
Carlos CastellaroArgentinian Society of Hypertension, Buenos Aires, Argentina.
Walter EspecheArgentinian Society of Hypertension, Buenos Aires, Argentina.
Alejandro De CerchioArgentinian Society of Hypertension, Buenos Aires, Argentina.
Mildren Del SueldoArgentinian Society of Hypertension, Buenos Aires, Argentina.
Sergio VissaniArgentinian Society of Hypertension, Buenos Aires, Argentina.
Judith ZilbermanArgentinian Society of Hypertension, Buenos Aires, Argentina.
Argentine Water and Sanitation (Argentina) · ARHospital Italiano de Buenos Aires · ARArgerich Hospital · ARCentro de Educación Médica e Investigaciones Clínicas Norberto Quirno · ARFundación Huésped · ARHospital de Clínicas "José de San Martín" · ARUniversity of Mendoza · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Worldwide, hypertension control rate is far from ideal. Some studies suggest that patients treated by specialists have a greater chance to achieve control. The authors aimed to determine the BP control rate among treated hypertensive patients under specialist care in Argentina, to characterize patients regarding their cardiovascular risk profile and antihypertensive drug use, and to assess the variables independently associated with adequate BP control. The authors included adult hypertensive patients under stable treatment, managed in 10 specialist centers across Argentina. Office BP was measured thrice with a validated oscillometric device. Adequate BP control was defined as an average of the three readings <140/90 mm Hg (and <150/90 in patients older than 80 years). The authors estimated the proportion of adequate BP control and the variables independently associated with it through a multiple conditional logistic regression model. Among the 1146 included patients, 48.2% were men with a mean age of 63.5 (±13.1) years old. Mean office BP was 135.3 (±14.8)/80.8 (±10) mm Hg, with a 64.8% (95% CI: 62%-67.6%) of adequate control. The mean number of antihypertensive drugs was 2.1 per participant, the commonest being angiotensin receptor blockers and calcium channel blockers. In multivariable analysis, only female sex was a predictor of adequate BP control (OR 1.33 [95% CI 1.02-1.72], P = .04). In conclusion, almost 65% of hypertensive patients treated in specialist centers in Argentina have adequate BP control. The challenge for future research is to define strategies in order to translate this control rate to the primary care level, where most patients are managed.

Indexed as

AgedAngiotensin Receptor AntagonistsAntihypertensive AgentsArgentinaBlood PressureBlood Pressure DeterminationCalcium Channel BlockersCardiovascular DiseasesCase-Control StudiesCross-Sectional StudiesFemaleHumansHypertensionMaleMiddle AgedPrimary Health CareAngiotensin Receptor AntagonistsAntihypertensive AgentsCalcium Channel Blockersblood pressure controlhypertensionrisk factorsspecialisttreatment

Identifiers

PMID31479195
PMCPMC8030316
OpenAlexW2971595658

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.